中文版
  • Company news


Oceanpine Capital closes RMB fund at $313m for Deep Tech bets

Jun 03, 2021

Oceanpine Capital has closed a new RMB-denominated fund at 2 billion yuan ($313.4 million) as it seeks to up the ante on deep technology investments...

Investee Company: China’s Xforceplus raises nearly $200m in Series C

Jun 01, 2021

Oceanpine Capital investee company——Xforceplus Information Technology has raked in $200 million in its Series C+ and C++ rounds of financing. This brings the total corpus raised by the IT company in its Series C round to about $200 million...

Investee Company: TinyChip Announced the Completion of Series A Financing

May 20, 2021

On May 20, 2021, Oceanpine Capital’s invested company, TinyChip announced the completion of tens of millions of RMB in Series A financing. This round of financing was led by Oceanpine Capital...

Oceanpine Theme Seminar ——“The status and development of the pharmaceutical industry” was successfully held in Beijing

May 10, 2021

on April 18th ,The Oceanpine Capital Investment Salon —— "The Current Status and Development of the Pharmaceutical Industry" was successfully held in Beijing...

Investee Company:Hepagene Therapeutics Inc. nets $40m in Series B1

Apr 26, 2021

Clinical stage drug discovery and development firm Hepagene Therapeutics Inc. on Tuesday said it has garnered a total of $40 million in its Series B1 round led by ByteDance-backer Loyal Valley Capital. Oceanpine Capital...

The 1st Oceanpine Capital Investment Salon in 2021 was successfully held in Beijing

Apr 23, 2021

On April 23, Oceanpine Capital's first salon of this year—— Digital Industry and New Retail Strategy Transformation was successfully held in China Century Building...

Investee Company:Horizon Robotics signed a strategic cooperation agreement with WILLSEMI and received strategic investment

Apr 22, 2021

On April 22, the investee company of Oceanpine Capital —— Horizon Robotics signed a strategic cooperation agreement with WILLSEMI and announced that it had received strategic investment from Weihao Chuangxin...

Investee Company:EdiGene Raises RMB 400 million in Series B Plus Financing

Apr 21, 2021

Apr. 21, 2021 -- EdiGene, Inc. ("Company", or "EdiGene"), today announced the successful completion of an RMB 400 million (approximately USD 62 million) Series B Plus financing...

Investee Company: TechnoDerma announced the completion of Series A financing

Apr 07, 2021

Technoderma is a leader in the research and development of innovative drugs for skin indications. The success of this round of financing provides a strong support to the company to rapidly advance the preclinical research and IND filing of its drug R&D pi

Investee Company:Immune-Onc Therapeutics Announces $73 Million in Series B1 and B2 Financing

Mar 31, 2021

Proceeds will support development of novel myeloid checkpoint inhibitors including its clinical program IO-202, a first-in-class LILRB4 antagonist antibody in blood cancers and solid tumors, and its preclinical programs IO-108 and IO-106...
12345678